Co-targeting thrombospondin-1 (THBS-1) to improve KRAS inhibitor and chemotherapeutic efficacy in pancreatic cancer (#268)

5:35 PM

Victoria M Tyma

Poster Session 2

Pinpointing and targeting novel drivers of pancreatic cancer progression and metastasis using TRAP-seq (#266)

5:35 PM

Michael Trpceski

Poster Session 2

Identifying and targeting FOLFIRINOX resistance mechanisms to improve outcomes in pancreatic cancer (#153)

5:40 PM

Katie Gordon

Welcome Reception & Poster Session 1

Temporally resolved proteomics identifies nidogen-2 as a co-target in pancreatic cancer that modulates fibrosis and therapy response (#235)

5:35 PM

Brooke Pereira

Poster Session 2

Pancreatic cancer secretome reveals PCSK9 as a co-target to sensitise tumours to chemotherapy and reduce metastasis (#244)

5:35 PM

Shona Ritchie

Poster Session 2

Targeting the NPY/NPY1R signaling axis impairs metastasis and tissue wasting in pancreatic cancer (#159)

5:40 PM

David Herrmann

Welcome Reception & Poster Session 1

Identifying and targeting treatment response mechanisms to improve Gemcitabine/Abraxane performance in Patient-Derived Models of Pancreatic Cancer (#263)

5:35 PM

Alice Tran

Poster Session 2

Targeting subcellular JNK activity in pancreatic cancer (#123)

5:40 PM

Antonia Cadell

Welcome Reception & Poster Session 1

Detecting changes in the tumour microenvironment and CAR T infiltration following chemotherapeutic priming using intravital imaging (#142)

5:40 PM

Marija Dinevska

Welcome Reception & Poster Session 1